Nature Communications (Jun 2021)

Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection

  • Peng Chen,
  • Ji Zeng,
  • Zheng Liu,
  • Hatim Thaker,
  • Siyu Wang,
  • Songhai Tian,
  • Jie Zhang,
  • Liang Tao,
  • Craig B. Gutierrez,
  • Li Xing,
  • Ralf Gerhard,
  • Lan Huang,
  • Min Dong,
  • Rongsheng Jin

DOI
https://doi.org/10.1038/s41467-021-23878-3
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Chondroitin sulfate proteoglycan 4 (CSPG4) is a potential receptor for C. difficile toxin B (TcdB) during C. difficile infections (CDIs). Here, the cryo-EM structure of a TcdB–CSPG4 complex and CDI mouse models offer insights into CSPG4 role in CDIs and suggest a therapeutic strategy targeting TcdB.